ID   AOFB_RAT                Reviewed;         520 AA.
AC   P19643; Q5EBB5;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 169.
DE   RecName: Full=Amine oxidase [flavin-containing] B {ECO:0000305};
DE            EC=1.4.3.21 {ECO:0000269|PubMed:20493079, ECO:0000269|PubMed:4156831};
DE            EC=1.4.3.4 {ECO:0000269|PubMed:20493079};
DE   AltName: Full=Monoamine oxidase type B;
DE            Short=MAO-B;
GN   Name=Maob {ECO:0000312|RGD:3041};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=2974701; DOI=10.1016/s0006-291x(88)80969-0;
RA   Ito A., Kuwahara T., Inadome S., Sagara Y.;
RT   "Molecular cloning of a cDNA for rat liver monoamine oxidase B.";
RL   Biochem. Biophys. Res. Commun. 157:970-976(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=4156831; DOI=10.1042/bj1440029;
RA   Seiler N., Al-Therib M.J.;
RT   "Putrescine catabolism in mammalian brain.";
RL   Biochem. J. 144:29-35(1974).
RN   [4]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6428396; DOI=10.1016/0006-291x(84)91293-2;
RA   Chiba K., Trevor A., Castagnoli N. Jr.;
RT   "Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine
RT   oxidase.";
RL   Biochem. Biophys. Res. Commun. 120:574-578(1984).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20493079; DOI=10.1016/0197-0186(86)90182-8;
RA   O'Carroll A.M., Bardsley M.E., Tipton K.F.;
RT   "The oxidation of adrenaline and noradrenaline by the two forms of
RT   monoamine oxidase from human and rat brain.";
RL   Neurochem. Int. 8:493-500(1986).
RN   [6]
RP   MUTAGENESIS OF ILE-199.
RX   PubMed=9162023; DOI=10.1074/jbc.272.22.14033;
RA   Tsugeno Y., Ito A.;
RT   "A key amino acid responsible for substrate selectivity of monoamine
RT   oxidase A and B.";
RL   J. Biol. Chem. 272:14033-14036(1997).
CC   -!- FUNCTION: Catalyzes the oxidative deamination of primary and some
CC       secondary amines such as neurotransmitters, and exogenous amines
CC       including the tertiary amine, neurotoxin 1-methyl-4-phenyl-1,2,3,6-
CC       tetrahydropyridine (MPTP), with concomitant reduction of oxygen to
CC       hydrogen peroxide and participates in the metabolism of neuroactive and
CC       vasoactive amines in the central nervous system and peripheral tissues
CC       (PubMed:20493079). Preferentially degrades benzylamine and
CC       phenylethylamine (PubMed:20493079). {ECO:0000269|PubMed:20493079}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a secondary aliphatic amine + H2O + O2 = a primary amine + an
CC         aldehyde + H2O2; Xref=Rhea:RHEA:26414, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:17478,
CC         ChEBI:CHEBI:58855, ChEBI:CHEBI:65296; EC=1.4.3.4;
CC         Evidence={ECO:0000269|PubMed:20493079};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-adrenaline + H2O + O2 = (R)-3,4-dihydroxymandelaldehyde +
CC         H2O2 + methylamine; Xref=Rhea:RHEA:51168, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:59338,
CC         ChEBI:CHEBI:71406, ChEBI:CHEBI:180943;
CC         Evidence={ECO:0000269|PubMed:20493079};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a primary methyl amine + H2O + O2 = an aldehyde + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:16153, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17478, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:228804; EC=1.4.3.21;
CC         Evidence={ECO:0000269|PubMed:20493079, ECO:0000269|PubMed:4156831};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16154;
CC         Evidence={ECO:0000305|PubMed:4156831};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dopamine + H2O + O2 = 3,4-dihydroxyphenylacetaldehyde + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:27946, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:27978, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:59905; Evidence={ECO:0000269|PubMed:20493079};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + tyramine = (4-hydroxyphenyl)acetaldehyde + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:30591, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15621, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:327995; Evidence={ECO:0000269|PubMed:20493079};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-noradrenaline + H2O + O2 = (R)-3,4-dihydroxymandelaldehyde
CC         + H2O2 + NH4(+); Xref=Rhea:RHEA:69076, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:72587, ChEBI:CHEBI:180943;
CC         Evidence={ECO:0000269|PubMed:20493079};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=benzylamine + H2O + O2 = benzaldehyde + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:59424, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17169, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:225238; Evidence={ECO:0000250|UniProtKB:P27338};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59425;
CC         Evidence={ECO:0000250|UniProtKB:P27338};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-phenylethylamine + H2O + O2 = 2-phenylacetaldehyde + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:25265, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:16424, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:225237; Evidence={ECO:0000269|PubMed:20493079};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-acetylputrescine + O2 = 4-acetamidobutanal + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:70283, ChEBI:CHEBI:7386, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58263; Evidence={ECO:0000269|PubMed:4156831};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70284;
CC         Evidence={ECO:0000269|PubMed:4156831};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:P27338};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=840 uM for (R)-adrenaline {ECO:0000269|PubMed:20493079};
CC         KM=290 uM for dopamine {ECO:0000269|PubMed:20493079};
CC         KM=533 uM for serotonin {ECO:0000269|PubMed:20493079};
CC         KM=1954 uM for (R)-noradrenaline {ECO:0000269|PubMed:20493079};
CC         KM=5 uM for 2-phenylethylamine {ECO:0000269|PubMed:20493079};
CC         KM=328 uM for tyramine {ECO:0000269|PubMed:20493079};
CC         Vmax=531 pmol/min/mg enzyme toward (R)-adrenaline
CC         {ECO:0000269|PubMed:20493079};
CC         Vmax=396 pmol/min/mg enzyme toward dopamine
CC         {ECO:0000269|PubMed:20493079};
CC         Vmax=125 pmol/min/mg enzyme toward serotonin
CC         {ECO:0000269|PubMed:20493079};
CC         Vmax=383 pmol/min/mg enzyme toward (R)-noradrenaline
CC         {ECO:0000269|PubMed:20493079};
CC         Vmax=489 pmol/min/mg enzyme toward 2-phenylethylamine
CC         {ECO:0000269|PubMed:20493079};
CC         Vmax=687 pmol/min/mg enzyme toward tyramine
CC         {ECO:0000269|PubMed:20493079};
CC   -!- SUBUNIT: Monomer, homo- or heterodimer (containing two subunits of
CC       similar size). Each subunit contains a covalently bound flavin.
CC       Enzymatically active as monomer (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass type IV
CC       membrane protein; Cytoplasmic side.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M23601; AAA41566.1; -; mRNA.
DR   EMBL; BC089814; AAH89814.1; -; mRNA.
DR   PIR; A31870; A31870.
DR   RefSeq; NP_037330.1; NM_013198.1.
DR   AlphaFoldDB; P19643; -.
DR   SMR; P19643; -.
DR   BioGRID; 247778; 1.
DR   STRING; 10116.ENSRNOP00000043466; -.
DR   BindingDB; P19643; -.
DR   ChEMBL; CHEMBL2993; -.
DR   DrugCentral; P19643; -.
DR   GuidetoPHARMACOLOGY; 2490; -.
DR   iPTMnet; P19643; -.
DR   PhosphoSitePlus; P19643; -.
DR   PaxDb; 10116-ENSRNOP00000043466; -.
DR   DNASU; 25750; -.
DR   Ensembl; ENSRNOT00000044009.6; ENSRNOP00000043466.4; ENSRNOG00000029778.6.
DR   Ensembl; ENSRNOT00055027658; ENSRNOP00055022193; ENSRNOG00055016304.
DR   Ensembl; ENSRNOT00060032306; ENSRNOP00060026318; ENSRNOG00060018700.
DR   Ensembl; ENSRNOT00065035977; ENSRNOP00065029013; ENSRNOG00065021133.
DR   GeneID; 25750; -.
DR   KEGG; rno:25750; -.
DR   UCSC; RGD:3041; rat.
DR   AGR; RGD:3041; -.
DR   CTD; 4129; -.
DR   RGD; 3041; Maob.
DR   eggNOG; KOG0029; Eukaryota.
DR   GeneTree; ENSGT00940000161545; -.
DR   HOGENOM; CLU_004498_0_1_1; -.
DR   InParanoid; P19643; -.
DR   OMA; PIHWAGT; -.
DR   OrthoDB; 5471885at2759; -.
DR   PhylomeDB; P19643; -.
DR   BRENDA; 1.4.3.4; 5301.
DR   Reactome; R-RNO-141333; Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB.
DR   SABIO-RK; P19643; -.
DR   PRO; PR:P19643; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000029778; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0052595; F:aliphatic amine oxidase activity; IEA:RHEA.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0097621; F:monoamine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0014063; P:negative regulation of serotonin secretion; IMP:RGD.
DR   GO; GO:0019607; P:phenylethylamine catabolic process; IDA:RGD.
DR   GO; GO:0045964; P:positive regulation of dopamine metabolic process; IMP:RGD.
DR   GO; GO:0010044; P:response to aluminum ion; IEP:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010269; P:response to selenium ion; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IDA:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   Gene3D; 3.90.660.10; -; 1.
DR   Gene3D; 6.10.250.130; -; 1.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 1.
DR   Gene3D; 1.10.405.10; Guanine Nucleotide Dissociation Inhibitor, domain 1; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR001613; Flavin_amine_oxidase.
DR   InterPro; IPR050703; Flavin_MAO.
DR   PANTHER; PTHR43563; AMINE OXIDASE; 1.
DR   PANTHER; PTHR43563:SF21; AMINE OXIDASE [FLAVIN-CONTAINING] B; 1.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   PRINTS; PR00757; AMINEOXDASEF.
DR   SUPFAM; SSF54373; FAD-linked reductases, C-terminal domain; 1.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
PE   1: Evidence at protein level;
KW   Acetylation; FAD; Flavoprotein; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Oxidoreductase; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P56560"
FT   CHAIN           2..520
FT                   /note="Amine oxidase [flavin-containing] B"
FT                   /id="PRO_0000099863"
FT   TOPO_DOM        2..489
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        490..516
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        517..520
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000250"
FT   SITE            156
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250"
FT   SITE            365
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250"
FT   SITE            382
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56560"
FT   MOD_RES         52
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BW75"
FT   MOD_RES         397
FT                   /note="S-8alpha-FAD cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P27338"
FT   MUTAGEN         139
FT                   /note="L->H: No change in substrate affinity."
FT   MUTAGEN         199
FT                   /note="I->F: Increased affinity for serotonin and
FT                   tyramine."
FT                   /evidence="ECO:0000269|PubMed:9162023"
FT   CONFLICT        38
FT                   /note="R -> C (in Ref. 1; AAA41566)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        335..336
FT                   /note="GS -> AG (in Ref. 1; AAA41566)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   520 AA;  58459 MW;  F2C230BC6CDE5840 CRC64;
     MSNKCDVIVV GGGISGMAAA KLLHDCGLSV VVLEARDRVG GRTYTIRNKN VKYVDLGGSY
     VGPTQNRILR LAKELGLETY KVNEVERLIH FVKGKSYAFR GPFPPVWNPI TYLDYNNLWR
     TMDEMGQEIP SDAPWKAPLA EEWDYMTMKE LLDKICWTNS TKQIATLFVN LCVTAETHEV
     SALWFLWYVK QCGGTTRIIS TTNGGQERKF IGGSGQVSER IKDILGDRVK LERPVIHIDQ
     TGENVVVKTL NHEIYEAKYV ISAIPPVLGM KIHHSPPLPI LRNQLITRVP LGSVIKCMVY
     YKEPFWRKKD FCGTMVIEGE EAPIAYTLDD TKPDGSCAAI MGFILAHKAR KLVRLTKEER
     LRKLCELYAK VLNSQEALQP VHYEEKNWCE EQYSGGCYTA YFPPGILTQY GRVLRQPVGK
     IFFAGTETAS HWSGYMEGAV EAGERAAREI LHAIGKIPED EIWQPEPESV DVPARPITNT
     FLERHLPSVP GLLKLLGLTT ILSATALGFL AHKKGLFVRF
//
